ReviewDrug design, development and therapy2017

Spotlight on blisibimod and its potential in the treatment of systemic lupus erythematosus: evidence to date.

Aleksander Lenert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.